Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular Carcinoma

NCT02403544 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Hepatocellular

Interventions

RADIATION: IGRT
DRUG: Capecitabine
DRUG: Oxaliplatin

Sponsor

Chinese Academy of Medical Sciences

Collaborators

[object Object]
[object Object]